Clinical Trials Browser

Interventional × Solid Tumor × Docetaxel × Clear all

NCT04827576 2025-05-08

ELEVATELung&UC

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

NCT04810208 2021-12-30

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04360317 2020-04-24

Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT02963168 2019-10-17

A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT02490475 2017-05-17

A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors

Phase 1 Completed

19 enrolled 25 charts

Other solid neoplasm

Solid Tumor

NCT02274610 2017-05-01

DOPNP201

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT01336582 2012-12-21

Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00251407 2012-08-09

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT00888108 2012-05-22

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor